Dieter Haemmerich, Ph.D.

I am a bioengineer and have about 15 years expertise in the research on image-guided thermal cancer therapies, and 8 years of experience in image-guided drug delivery with thermosensitive liposomes (TSL). Triggered nanoparticles such as TSL have potential as novel cancer therapies as they allow the targeted delivery of chemotherapy agents and other drugs to targeted tissue regions. I have extensive expertise in computational modeling of both hyperthermia devices as well as drug delivery systems such as TSL and, together with a colleague, established the “IEEE EMBS international summer school for Computational Modeling in Medicine” that was held for the 3rd time this year. In addition, I have expertise in in vivo studies (rodents and large animals, including porcine and canine models) of thermal therapies and liposomal drug delivery, as well as in vivo fluorescence imaging and image processing.